What B and D vitamins can actually change in autism and ADHD, according to the evidence

A new meta-analysis in Neuropsychiatric Disease and Treatment pooled 652 people with autism spectrum disorder and 852 people with ADHD from trials indexed in PubMed, Web of Science and Cochrane Library, and found a split worth taking seriously: B vitamins tracked with improvements in emotional and behavioral symptoms and reduced stereotyped behaviors in autism, while vitamin D tracked with gains in attention and some behavioral problems in ADHD. The authors, led by Yonghui Shen and colleagues, frame this as evidence that the two nutrients act on different conditions rather than functioning as a general fix for neurodevelopmental symptoms.

That specificity is the actual finding, and it is also where caution has to start. A systematic review and meta-analysis of this kind combines many small trials that differ in dose, duration, age of participants and how symptoms were measured, which inflates the apparent strength of a pooled result compared with any single study. The paper does not establish that giving a child vitamin B or D will change outcomes in a way that holds up outside the specific, often short, trial windows the included studies used.

The vitamin D and ADHD line has a track record of research but not of settled results. A separate body of work has looked at vitamin D levels rather than supplementation: a 2026 study in Scientific Reports found that adults with ADHD had significantly lower serum B12 and 25-hydroxyvitamin D than healthy controls, with lower levels tracking greater symptom severity. That is an association between blood levels and symptoms, not proof that raising the vitamin level through a pill changes the symptoms. The field still treats the question as open: clinical trials such as NCT03103750, testing vitamin D as an add-on to stimulant treatment for ADHD, are registered and ongoing rather than already reporting a verdict.

On the autism side, the B-vitamin finding sits in tension with how specialist groups have evaluated the same category of supplement in the past. The Association for Science in Autism Treatment has described vitamin therapy for autism as unsupported by research, pointing to well-designed trials of B6 combined with magnesium that found no behavioral effect. That earlier null result does not erase the new meta-analysis, but it is the kind of contradictory evidence a family should know about before reading the headline as settled science.

The strongest data in this area right now points to a different window than the one in the headline. A pregnancy-focused meta-analysis found that higher maternal vitamin D during pregnancy was linked to a roughly 9 percent drop in offspring autism risk per 10 nmol/L increase in maternal serum vitamin D, and a Danish case-cohort study published in Lancet Psychiatry linked neonatal vitamin D status inversely to risk of autism, ADHD, and schizophrenia. Those are studies of vitamin exposure before or at birth, affecting risk of a diagnosis developing at all. They say nothing about whether supplementing a child already diagnosed with autism or ADHD will change their symptoms, which is the claim the new meta-analysis is actually testing.

What the evidence supports, for now, is narrow: a correlation between vitamin D and B-vitamin status and symptom patterns, a pooled signal from heterogeneous small trials that B vitamins may help certain autism symptoms and vitamin D may help certain ADHD symptoms, and an open set of registered trials, including a high-dose B6-plus-magnesium trial in children with autism, NCT04509401, still working through the question. None of that supports buying a supplement off a pharmacy shelf and expecting it to replace stimulant medication, behavioral therapy or applied behavior analysis. The one step with clear backing across every version of this research is the blood test: checking a child's actual vitamin D and B12 levels before deciding whether supplementation is even relevant to their case.